Skip to content

Clinical trials

Scleroderma, Diffuse trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: Italy Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20131
20151
20161
20192
20201
20211
20223
20234
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Recruiting4
Terminated4
Withdrawn1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
CSL Behring2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Amgen1
Artiva Biotherapeutics, Inc.1
AstraZeneca1
Bristol-Myers Squibb1
Emoled1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Fondazione Policlinico Universitario Campus Bio-Medico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse22
Scleroderma, Systemic10
Lung Diseases, Interstitial5
Fibrosis3
Arthritis, Rheumatoid2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Autoimmune Diseases1
Connective Tissue Diseases1
Dermatomyositis1
Immune System Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.